Journal Home > Volume 11 , Issue 1

The therapeutic effect of gamma-aminobutyric acid (GABA) on diabetes was spread as one of the alarming epidemics worldwide. The study aims to investigate the function of Lactobacillus brevis KLDS1.0727 and KLDS1.0373 strains as glutamic acid decarboxylase 65 (GAD65) carriers capable of generating GABA by comparing in vitro free and freeze-dried models and GABA intervention in vivo. PCR amplification of gad and in vitro i.e., (growth rate, viability at different pH, bile tolerance, and survivability in simulated gastric juice) were performed. In vivo experiments were conducted in 7 groups of C57BL/6J mice. Each group was injected with streptozotocin (ContSTZ, INSSTZ, LAC1STZ, LAC1MFDSTZ, LAC2STZ, LAC2MFDSTZ) daily except for the control (Cont). One group was injected with insulin (INSSTZ). The body weight and hyperglycemia in the blood were assessed weekly, post-euthanasia blood plasma parameters, insulin, and histological examination were evaluated. Results indicated L. brevis strains demonstrated a great tolerance to bile and simulated gastric juice in vitro (P < 0.05). ContSTZ had the highest average glucose level (6.84±6.46) mmol/L while INSSTZ expressed dramatically decreed in glucose level and displayed a significant decline in the average of weekly blood glucose (−5.74±3.08) mmol/L. The lowest body weight (ContSTZ) was (19.30±0.25) g. Based on the blood plasma analysis, L. brevis strains improved good cholesterol properties, liver and kidney functions, where most of these parameters fall within the average the reference range and prevent the development of symptoms of type 1 diabetes in vivo. As recommended, L. brevis should be commonly distributed as a postbiotic GABA in pharmaceutical and nutritional applications.


menu
Abstract
Full text
Outline
About this article

Verification of Lactobacillus brevis tolerance to simulated gastric juice and the potential effects of postbiotic gamma-aminobutyric acid in streptozotocin-induced diabetic mice

Show Author's information Amro Abdelazeza,b,c( )Heba Abdelmotaalb,dSmith Etareri Eviviea,eMaha BikheetfRokayya SamigHassan Mohamedh,iXiangchen Menga( )
Key Laboratory of Dairy Science, Ministry of Education, College of Food Sciences, Northeast Agricultural University, Harbin 150030, China
College of Agriculture and Forestry, Linyi University, Linyi 276005, China
Department of Dairy Microbiology, Animal Production Research Institute, Agriculture Research Centre, Dokki, Giza 12618, Egypt
Department of Microbiology, Soil, Water, Environment, and Microbiology Research Institute, Agriculture Research Centre, Giza 12619, Egypt
Department of Food Science & Hunan Nutrition, Faculty of Agriculture, University of Benin, Benin City 300001, Nigeria
Department of Dairy Science, Faculty of Agriculture, Minia University, Minia 61511, Egypt
Department of Food Science and Nutrition, College of Sciences, Taif University, P. O. 11099, Taif 21944, Saudi Arabia
Colin Ratledge Center for Microbial Lipids, School of Agriculture Engineering and Food Science, Shandong University of Technology, Zibo 255049, China
Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, Assiut 71524, Egypt

Peer review under responsibility of KeAi Communications Co., Ltd.

Abstract

The therapeutic effect of gamma-aminobutyric acid (GABA) on diabetes was spread as one of the alarming epidemics worldwide. The study aims to investigate the function of Lactobacillus brevis KLDS1.0727 and KLDS1.0373 strains as glutamic acid decarboxylase 65 (GAD65) carriers capable of generating GABA by comparing in vitro free and freeze-dried models and GABA intervention in vivo. PCR amplification of gad and in vitro i.e., (growth rate, viability at different pH, bile tolerance, and survivability in simulated gastric juice) were performed. In vivo experiments were conducted in 7 groups of C57BL/6J mice. Each group was injected with streptozotocin (ContSTZ, INSSTZ, LAC1STZ, LAC1MFDSTZ, LAC2STZ, LAC2MFDSTZ) daily except for the control (Cont). One group was injected with insulin (INSSTZ). The body weight and hyperglycemia in the blood were assessed weekly, post-euthanasia blood plasma parameters, insulin, and histological examination were evaluated. Results indicated L. brevis strains demonstrated a great tolerance to bile and simulated gastric juice in vitro (P < 0.05). ContSTZ had the highest average glucose level (6.84±6.46) mmol/L while INSSTZ expressed dramatically decreed in glucose level and displayed a significant decline in the average of weekly blood glucose (−5.74±3.08) mmol/L. The lowest body weight (ContSTZ) was (19.30±0.25) g. Based on the blood plasma analysis, L. brevis strains improved good cholesterol properties, liver and kidney functions, where most of these parameters fall within the average the reference range and prevent the development of symptoms of type 1 diabetes in vivo. As recommended, L. brevis should be commonly distributed as a postbiotic GABA in pharmaceutical and nutritional applications.

Keywords: In vitro, Diabetes, Gamma-aminobutyric acid, Postbiotics, Lactobacillus brevis, C57BL/6J mice

References(78)

[1]

G. Suzzi, A. Corsetti, Food Microbiology: the past and the new challenges for the next 10 years, Front. Microbiol. 11 (2020). https://doi.org/10.3389/fmicb.2020.00237.

[2]

S. Turroni, M. Magnani, P. Kc, et al., Gut microbiome and space travelers' health: state of the art and possible pro/prebiotic strategies for long-term space missions, Front Physiol. 11 (2020) 1135. https://doi.org/10.3389/fphys.2020.553929.

[3]

A. Singh, V. Vishwakarma, B. Singhal, Metabiotics: the functional metabolic signatures of probiotics: current state-of-art and future research priorities—metabiotics: probiotics effector molecules, Adv. Biosci. Biotechnol. 9 (2018) 147-189. https://doi.org/10.4236/abb.2018.94012.

[4]

J. Aguilar-Toalá, R. Garcia-Varela, H. Garcia, et al., Postbiotics: an evolving term within the functional foods field, Trends. Food Sci. Tech. 75 (2018) 105-114. https://doi.org/10.1016/j.tifs.2018.03.009.

[5]

R.G. Kerry, J.K. Patra, S. Gouda, et al., Benefaction of probiotics for human health: a review, J. Food Drug Anal. 26 (2018) 927-939. https://doi.org/10.1016/j.jfda.2018.01.002.

[6]

M.T. Hasan, W.J. Jang, B.J. Lee, et al., Heat-killed Bacillus sp. SJ-10 probiotic acts as a growth and humoral innate immunity response enhancer in olive flounder (Paralichthys olivaceus), Fish Shellfish Immun. 88 (2019) 424-431. https://doi.org/10.1016/j.fsi.2019.03.018.

[7]

H.S. Lim, D.H. Seo, I.T. Cha, et al., Expression and characterization of glutamate decarboxylase from Lactobacillus brevis HYE1 isolated from kimchi, World J. Microbiol. Biotechnol. 34 (2018) 44. https://doi.org/10.1007/s11274-018-2427-6.

[8]

S. Bagheri, A. Heydari, A. Alinaghipour, et al., Effect of probiotic supplementation on seizure activity and cognitive performance in PTZ-induced chemical kindling, Epilepsy Behav. 95 (2019) 43-50. https://doi.org/10.1016/j.yebeh.2019.03.038.

[9]

A. Abdelazez, H. Abdelmotaal, S.E. Evivie, et al., Screening potential probiotic characteristics of Lactobacillus brevis strains in vitro and intervention effect on type I diabetes in vivo, Biomed Res. Int. 2018 (2018) 7356173. https://doi.org/10.1155/2018/7356173.

[10]

G.S. Forkuo, A.N. Nieman, N.Y. Yuan, et al., Alleviation of multiple asthmatic pathologic features with orally available and subtype-selective GABAA receptor modulators, Mol. Pharmaceut. 14 (2017) 2088-2098. https://doi.org/10.1021/acs.molpharmaceut.7b00183.

[11]

L. Song, A. Du, Y. Xiong, et al., γ-Aminobutyric acid inhibits the proliferation and increases oxaliplatin sensitivity in human colon cancer cells, Tumor Biolo. 37 (2016) 14885-14894. https://doi.org/10.1007/s13277-016-5367-5.

[12]

M.J. Callan, H. Kim, W.J. Matthews, Predicting self-rated mental and physical health: the contributions of subjective socioeconomic status and personal relative deprivation, Front. Psychol. 6 (2015) 1415. https://doi.org/10.3389/fpsyg.2015.01415.

[13]

Q. Wu, N.P. Shah, High γ-aminobutyric acid production from lactic acid bacteria: emphasis on Lactobacillus brevis as a functional dairy starter, Crit. Rev. Food Sci. Nutr. 57 (2017) 3661-3672. https://doi.org/10.1080/10408398.2016.1147418.

[14]

F.E. Turkheimer, R. Leech, P. Expert, et al., The brain's code and its canonical computational motifs. from sensory cortex to the default mode network: a multi-scale model of brain function in health and disease, Neurosci. Biobehav. Rev. 55 (2015) 211-222. https://doi.org/10.1016/j.neubiorev.2015.04.014.

[15]

M. Mele, R.O. Costa, C.B. Duarte, Alterations in GABAA-receptor trafficking and synaptic dysfunction in brain disorders, Front. Cell Neurosci. 13 (2019). https://doi.org/10.3389/fncel.2019.00077.

[16]

E. Cassani, M. Barichella, R. Cancello, et al., Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease, Parkinsonism Relat. Disord. 21 (2015) 389-393. https://doi.org/10.1016/j.parkreldis.2015.02.004.

[17]

M. Ogawa, T. Nagai, Y. Saito, et al., Short-term mastication after weaning upregulates GABAergic signalling and reduces dendritic spine in thalamus, Biochem. Biophys. Res. Commun. 498 (2018) 621-626. https://doi.org/10.1016/j.bbrc.2018.03.032.

[18]

A. Adikari, M. Appukutty, G. Kuan, Effects of daily probiotics supplementation on anxiety induced physiological parameters among competitive football players, Nutrients 12 (2020) 1920. https://doi.org/10.3390/nu12071920.

[19]

N. Xu, L. Wei, J. Liu, Biotechnological advances and perspectives of gamma-aminobutyric acid production, World J. Microbiol. Biotechnol. 33 (2017) 64. https://doi.org/10.1007/s11274-017-2234-5.

[20]

P. Yu, Q. Ren, X. Wang, et al., Enhanced biosynthesis of γ-aminobutyric acid (GABA) in Escherichia coli by pathway engineering, Biochem. Eng. J. 141 (2019) 252-258. https://doi.org/10.1016/j.bej.2018.10.025.

[21]

G.D. Huang, J. Mao, Z. Ji, et al., Sodium L-glutamate-induced physiological changes in Lactobacillus brevis NCl912 during GABA production under acidic conditions, Am. J. Biochem. Biotechnol. 10 (2014) 251-259. https://doi.org/10.3844/ajbbsp.2014.251.259.

[22]

M. Sano, M. Dohmoto, S. Ohashi, Characterization of the gatA gene from Aspergillus oryzae, Int. J. Biol. Macromol. 16 (2016) 9-15. https://doi.org/10.14533/jbm.16.9.

[23]

L. Diez-Gutiérrez, L. San Vicente, L.J.R. Barrón, et al., Gamma-aminobutyric acid, and probiotics: multiple health benefits and their future in the global functional food and nutraceuticals market, J. Funct. Foods 64 (2020) 103669. https://doi.org/10.1016/j.jff.2019.103669.

[24]

A. Zepeda-Hernández, L.E. Garcia-Amezquita, T. Requena, et al., Probiotics, prebiotics, and synbiotics added to dairy products: uses and applications to manage type 2 diabetes, Food Res. Int. 142 (2021) 110208. https://doi.org/10.1016/j.foodres.2021.110208.

[25]

A.O. Yu, J.H. Leveau, M.L. Marco, et al., Abundance, diversity and plant-specific adaptations of plant-associated lactic acid bacteria, Environ. Microbiol. Rep. 12 (2020) 16-29. https://doi.org/10.1111/1758-2229.12794.

[26]

Z. Nasiri, H. Montazeri, N. Akbari, et al., Synergistic cytotoxic and apoptotic effects of local probiotic Lactobacillus brevis isolated from regional dairy products in combination with Tamoxifen, Nutr. Cancer. 73 (2021) 290-299. https://doi.org/10.1080/01635581.2020.1743871.

[27]

I.S. Choi, H.M. Kim, S.G. Wi, et al., Effect of cation influx on the viability of freeze-dried Lactobacillus brevis WiKim0069, Appl. Sci. 8 (2018) 2189. https://doi.org/10.3390/app8112189.

[28]

S. Pieniz, R. Andreazza, T. Anghinoni, et al., Probiotic potential, antimicrobial and antioxidant activities of Enterococcus durans strain LAB18s, Food Control 37 (2014) 251-256. https://doi.org/10.1016/j.foodcont.2013.09.055.

[29]

M. Fukao, K. Oshima, H. Morita, et al., Genomic analysis by deep sequencing of the probiotic Lactobacillus brevis KB290 harboring nine plasmids reveals genomic stability, PLoS One 8 (2013) e60521. https://doi.org/10.1371/journal.pone.0060521.

[30]

I.M. Barmpalia-Davis, I. Geornaras, P.A. Kendall, et al., Effect of fat content on survival of Listeria monocytogenes during simulated digestion of inoculated beef frankfurters stored at 7null℃, Food Microbiol. 26 (2009) 483-490. https://doi.org/10.1016/j.fm.2009.02.011.

[31]

M. Khalf, N. Dabour, I. Fliss, Viability of probiotic bacteria in maple sap products under storage and gastrointestinal conditions, Bioresour. Technol. 101 (2010) 7966-7972. https://doi.org/10.1016/j.biortech.2010.05.053.

[32]

C.H. Wu, S.M. Huang, J.A. Lin, et al., Inhibition of advanced glycation endproduct formation by foodstuffs, Food Funct. 2 (2011) 224-234. https://doi.org/10.1039/c1fo10026b.

[33]

P. Purohit, Estimation of serum insulin, homeostasis model assessment-insulin resistance and C-peptide can help identify possible cardiovascular disease risk in thyroid disorder patients, Indian J. Endocrinol. Metab. 16 (2012) S97-S103. https://doi.org/10.4103/2230-8210.94263.

[34]

L. Chen, D.J. Magliano, P.Z. Zimmet, The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives, Nat. Rev. Endocrinol. 8 (2011) 228-236. https://doi.org/10.1038/nrendo.2011.183.

[35]

K. Hiraga, Y. Ueno, K. Oda, Glutamate decarboxylase from Lactobacillus brevis: activation by ammonium sulfate, Biosci. Biotechnol. Biochem. 72 (2008) 1299-1306. https://doi.org/10.1271/bbb.70782.

[36]

Q. Wu, H.M. Tun, Y.S. Law, Common distribution of gad operon in Lactobacillus brevis and its gadA contributes to efficient GABA synthesis toward cytosolic near-neutral pH, Front. Microbiol. 8 (2017) 206. https://doi.org/10.3389/fmicb.2017.00206.

[37]

Z.E. Ilhan, J.K. DiBaise, S.E. Dautel, et al., Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery, Npj Biofilms Microbi. 6 (2020) 1-12. https://doi.org/10.1038/s41522-020-0122-5.

[38]

R. Francavilla, F. Cristofori, M. Vacca, et al., Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease, Expert. Rev. Gastroenterol. Hepatol. 14 (2020) 323-333. https://doi.org/10.1080/17474124.2020.1745630.

[39]

M.J. Davoren, J. Liu, J. Castellanos, et al., A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period, Gut Microbes. 10 (2019) 458-480. https://doi.org/10.1080/19490976.2018.1547612.

[40]

M.R. Rickels, Metabolic and endocrine evaluation of islet transplant function, transplantation, bioengineering, and regeneration of the endocrine pancreas, Elsevier (2020) pp. 565-578. https://doi.org/10.1016/B978-0-12-814833-4.00045-9.

[41]

C. Zhang, Z. Yu, J. Zhao, et al., Colonization and probiotic function of Bifidobacterium longum, J. Funct. Foods 53 (2019) 157-165. https://doi.org/10.1016/j.jff.2018.12.022.

[42]

L. Valdés-Varela, A.M. Hernández-Barranco, P. Ruas-Madiedo, et al., Effect of Bifidobacterium upon Clostridium difficile growth and toxicity when co-cultured in different prebiotic substrates, Front. Microbiol. 7 (2016) 738. https://doi.org/10.3389/fmicb.2016.00738.

[43]

E. Sherwin, K.V. Sandhu, T.G. Dinan, et al., May the force be with you: the light and dark sides of the microbiota-gut-brain axis in neuropsychiatry, CNS Drugs 30 (2016) 1019-1041. https://doi.org/10.1007/s40263-016-0370-3.

[44]

F. Sotoudegan, M. Daniali, S. Hassani, et al., Reappraisal of probiotics' safety in human, Food Chem. Toxicol 129 (2019) 22-29. https://doi.org/10.1016/j.fct.2019.04.032.

[45]

C.G. Tsiouris, M.G. Tsiouri, Human microflora, probiotics, and wound healing, Int Wound J. 19 (2017) 33-38. https://doi.org/10.1016/j.wndm.2017.09.006.

[46]

A. Di Cerbo, B. Palmieri, M. Aponte, et al., Mechanisms and therapeutic effectiveness of lactobacilli, J. Clin. Pathol. 69 (2016) 187-203. https://doi.org/10.1136/jclinpath-2015-202976.

[47]

G. Novik, V. Savich, Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine, Microbes Infect. 22 (2019) 8-18. https://doi.org/10.1016/j.micinf.2019.06.004.

[48]

Q. Wang, X. Liu, J. Fu, et al., Substrate sustained release-based high efficacy biosynthesis of GABA by Lactobacillus brevis NCL912, Microb. Cell Fact. 17 (2018) 80. https://doi.org/10.1186/s12934-018-0919-6.

[49]

M. Hasegawa, S. Fujii, K. Funato, et al., Expression of two glutamate decarboxylase genes in Lactobacillus brevis during gamma-aminobutyric acid production with date residue extract, Biosci. Biotechnol. Biochem. 84 (2020) 1069-1072. https://doi.org/10.1080/09168451.2020.1714422.

[50]

M. Wang, F. Gao, H. Zheng, et al., Microencapsulation of ginsenosides using polymerized whey protein (PWP) as wall material and its application in probiotic fermented milk, Int. J. Food Sci. Tech. 52 (2017) 1009-1017. https://doi.org/10.1111/ijfs.13365.

[51]

G.Q. Wang, J. Pu, X.Q. Yu, et al., Influence of freezing temperature before freeze-drying on the viability of various Lactobacillus plantarum strains, J. Dairy Sci. 103 (2020) 3066-3075. https://doi.org/10.3168/jds.2019-17685.

[52]

G. Broeckx, D. Vandenheuvel, I.J. Claes, et al., Drying techniques of probiotic bacteria as an important step towards the development of novel pharmabiotics, Int. J. Pharm. 505 (2016) 303-318. https://doi.org/10.1016/j.ijpharm.2016.04.002.

[53]

S. Rathore, P.M. Desai, C.V. Liew, et al., Microencapsulation of microbial cells, J. Food Eng. 116 (2013) 369-381. https://doi.org/10.1016/j.jfoodeng.2012.12.022.

[54]

M.J. Martín, F. Lara-Villoslada, M.A. Ruiz, et al., Microencapsulation of bacteria: a review of different technologies and their impact on the probiotic effects, Innov. Food Sci. Emerg. Technol. 27 (2015) 15-25. https://doi.org/10.1016/j.ifset.2014.09.010.

[55]

Q. Liao, X. Hang, X. Liu, et al., The influence of pH on heat stress response by probiotic Lactobacillus plantarum LP-Onlly, Ann. Microbiol. 60 (2010) 341-348. https://doi.org/10.1007/s13213-010-0048-x.

[56]

D.M. Mudie, K. Murray, C.L. Hoad, et al., Quantification of gastrointestinal liquid volumes and distribution following a 240nullmL dose of water in the fasted state, Mol. Pharm. 11 (2014) 3039-3047. https://doi.org/10.1021/mp500210c.

[57]

W. Charteris, P. Kelly, L. Morelli, et al., Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract, J. Appl. Microbiol. 84 (1998) 759-768. https://doi.org/10.1046/j.1365-2672.1998.00407.x.

[58]

C. Dunne, L. O'Mahony, L. Murphy, et al., In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings, Am. J. Clin. Nutr. 73 (2001) 386s-392s. https://doi.org/10.1093/ajcn/73.2.386s.

[59]

N. Gautam, N. Sharma, Evaluation of probiotic potential of new bacterial strain, Lactobacillus spicheri G2 isolated from Gundruk, Proc. Natl. Acad. Sci. India B. 85 (2015) 979-986. https://doi.org/10.1007/s40011-014-0458-9.

[60]

A. Di Ciaula, G. Garruti, R. Lunardi Baccetto, et al., Bile acid physiology, Ann. Hepatol. 16 (2018) 4-14. https://doi.org/10.5604/01.3001.0010.5493.

[61]

M. Hyacinta, K.S. Hana, B. Andrea, Bile tolerance and its effect on antibiotic susceptibility of probiotic Lactobacillus candidates, Folia Microbiol. 60 (2015) 253-257. https://doi.org/10.1007/s12223-014-0365-8.

[62]

J. Tian, Y. Lu, H. Zhang, et al., γ-Aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model, J Immunol. 173 (2004) 5298-5304. https://doi.org/10.4049/jimmunol.173.8.5298.

[63]

M.J. Mbiti, D.A. Orinda, P.J. Ojwang, Reference intervals for some biochemical parameters in the aged Kenyan population, East Afr. Med. J. 71 (1994) 84-87

[64]

D.H. Wasserman, Four grams of glucose, Am. J. Physiol. Endocrinol. 296 (2009) E11-E21. https://doi.org/10.1152/ajpendo.90563.2008.

[65]

D.B. Sacks, M. Arnold, G.L. Bakris, et al., Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus, Clin. Chem. 57 (2011) e1-e47. https://doi.org/10.1373/clinchem.2010.161596.

[66]

G. Rees, J. Xie, E.K. Fenwick, et al., Association between diabetes-related eye complications and symptoms of anxiety and depression, JAMA Ophthalmology 134 (2016) 1007-1014. https://doi.org/10.1001/jamaophthalmol.2016.2213.

[67]

W.G. Members, D. Lloyd-Jones, R.J. Adams, et al., Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association, Circulation. 121 (2010) 948-954. https://doi.org/10.1161/CIRCULATIONAHA.109.192667.

[68]

S.J. Bailey, M.A. Ravier, G.A. Rutter, Glucose-dependent regulation of gamma-aminobutyric acid (GABA A) receptor expression in mouse pancreatic islet alpha-cells, Diabetes 56 (2007) 320-327. https://doi.org/10.2337/db06-0712.

[69]

N. Soltani, H. Qiu, M. Aleksic, et al., GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 11692-11697. https://doi.org/10.1073/pnas.1102715108.

[70]

P. Thota, F.R. Perez-Lopez, V.A. Benites-Zapata, et al., Obesity-related insulin resistance in adolescents: a systematic review and meta-analysis of observational studies, Gynecol Endocrinol. 33 (2017) 179-184. https://doi.org/10.1080/09513590.2016.1273897.

[71]

T. Graham, C. Wason, M. Blüher, et al., Shortcomings in methodology complicate measurements of serum retinol-binding protein (RBP4) in insulin-resistant human subjects, Diabetologia 50 (2007) 814-823. https://doi.org/10.1007/s00125-006-0557-0.

[72]

M.R. McGill, The past and present of serum aminotransferases and the future of liver injury biomarkers, EXCLI J. 15 (2016) 817-828. https://doi.org/10.17179/excli2016-800.

[73]

K. Renuka, N. Parvathi, S.P. Subramanian, Biochemical studies on the antidiabetic properties of immature palmyra palm fruits studied in high-fat diet fed-low dose streptozotocin-induced type 2 diabetes in rats, GSC Biol. Pharm. Sci. 12 (2020) 223-235. https://doi.org/10.30574/gscbps.2020.12.3.0304.

[74]

P.N. Newsome, R. Cramb, S.M. Davison, et al., Guidelines on the management of abnormal liver blood tests, Gut 67 (2018) 6-19. https://doi.org/10.1136/gutjnl-2017-314924.

[75]

M. Bernardi, C. Maggioli, G. Zaccherini, Human albumin in the management of complications of liver cirrhosis, Crit. Care Med. 16 (2012) 211. https://doi.org/10.1186/cc11218.

[76]

M. Brownlee, The pathobiology of diabetic complications: a unifying mechanism, Diabetes 54 (2005) 1615-1625. https://doi.org/10.2337/diabetes.54.6.1615.

[77]

A.S. Ibraheem, A.A. Seleem, M.F. El-Sayed, et al., Single or combined cadmium and aluminum intoxication of mice liver and kidney with possible effect of zinc, JOBAZ 77 (2016) 91-101. https://doi.org/10.1016/j.jobaz.2016.12.004.

[78]

P.E. Stevens, A. Levin, Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline, Ann. Intern. Med. 158 (2013) 825-830. https://doi.org/10.7326/0003-4819-158-11-201306040-00007.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 09 December 2020
Revised: 09 March 2021
Accepted: 22 April 2021
Published: 11 September 2021
Issue date: January 2022

Copyright

© 2021 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Acknowledgements

The authors gratefully thanks to Taif University Researchers Supporting Project Number (TURSP-2020/140), Taif University, Taif, Saudi Arabia. As well as Dr. Mahmoud Helal, Faculty of Engineering, Taif University for his assistance in the statistical analysis.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return